trending Market Intelligence /marketintelligence/en/news-insights/trending/Ef3kY81bsAW10aPJ4hh7kA2 content esgSubNav
In This List

Outlook Therapeutics to implement 1-for-8 reverse stock split

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Outlook Therapeutics to implement 1-for-8 reverse stock split

Outlook Therapeutics Inc.'s board approved a 1-for-8 reverse split of its common stock.

The Cranbury, N.J.-based biopharmaceutical company's common shares will begin trading on a reverse split-adjusted basis from March 18 on the Nasdaq Capital Market.

Outlook's shareholders have already approved the plan.

American Stock Transfer & Trust Co. LLC, which is the company's transfer agent, is acting as the exchange agent for the stock split.